Tags: Drug.
Technetium (99mTc) votumumab (trade name HumaSPECT) is a human monoclonal antibody labelled with the radionuclide technetium-99m. It was developed for the detection of colorectal tumors but has never been marketed.The target of votumumab is CTAA16.88 a complex of cytokeratin polypeptides in the molecular weight range of 35 to 43 kDa which is expressed in colorectal tumors.